Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy

Journal of Veterinary Cardiology

Volumn 11, Issue SUPPL. 1, 2009, Pages

  Hsu, Adonia ^a   Kittleson, Mark D ^a   Paling, Anna ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BNP; Cat; Hypertrophic cardiomyopathy; Natriuretic peptide; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; MYOSIN BINDING PROTEIN C;

ACCURACY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CAT; CONTROLLED STUDY; CROSS BREEDING; DIAGNOSTIC VALUE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HYPERTROPHIC CARDIOMYOPATHY; MALE; MEDICAL ASSESSMENT; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANIMALS; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; CASE-CONTROL STUDIES; CAT DISEASES; CATS; ECHOCARDIOGRAPHY; FEMALE; MALE; MASS SCREENING; MUTATION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

ANIMALIA; FELIDAE;

EID: 67349276406     PISSN: 17602734     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvc.2009.02.005     Document Type: Article

References (26)

1. Meurs K.M., Sanchez X., David R.M., Bowles N.E., Towbin J.A., Reiser P.J., Kittleson J.A., Munro M.J., Dryburgh K., Macdonald K.A., and Kittleson M.D. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Hum Mol Genet 14 (2005) 3587-3593
2. Meurs K.M., Norgard M.M., Ederer M.M., Hendrix K.P., and Kittleson M.D. A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy. Genomics 90 (2007) 261-264
3. Kittleson M.D., and Kienle R.D. Small animal cardiovascular medicine (1998), Mosby, St. Louis, MO
4. Gavaghan B.J., Kittleson M.D., Fisher K.J., Kass P.H., and Gavaghan M.A. Quantification of left ventricular diastolic wall motion by Doppler tissue imaging in healthy cats and cats with cardiomyopathy. Am J Vet Res 60 (1999) 1478-1486
5. Bonagura J.D. Feline echocardiography. J Fel Med Surg 2 (2000) 147-151
6. Rishniw M., and Thomas W.P. Dynamic right ventricular outflow obstruction: a new cause of systolic murmurs in cats. J Vet Intern Med 16 (2002) 547-552
7. Goetze J.P. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 50 (2004) 1503-1510
8. Sisson D.D. Neuroendocrine evaluation of cardiac disease. Vet Clin North Am Small Anim Pract 34 (2004) 1105-1126
9. de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
10. Kaski J.P., Tome-Esteban M.T., Mead-Regan S.J., Pantazis A., Marek J., Deanfield J.E., McKenna W.J., and Elliott P.M. B-Type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy. Heart 94 (2008) 1307-1311
11. Maron B.J., Tholakanahalli V.N., Zenovich A.G., Casey S.A., Duprez D., Aeppli D.M., and Cohn J.N. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 109 (2004) 984-989
12. Efthimiadis G.K., Hitoglou-Makedou A., Giannakoulas G., Mitakidou A., Karamitsos T., Karvounis H., Mochlas S., Styliadis I., Stefanidis H., Parcharidis G., and Louridas G. Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy. Heart Vessels 22 (2007) 322-327
13. Arteaga E., Araujo A.Q., Buck P., Ianni B.M., Rabello R., and Mady C. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy. Am Heart J 150 (2005) 1228-1232
14. Kim S.W., Park S.W., Lim S.H., Kwon S.U., Choi Y.J., Park M.K., Lee S.C., Lee S.H., Park J.E., and Jeon E.S. Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction. Clin Cardiol 29 (2006) 155-160
15. Hori Y., Yamano S., Iwanaga K., Kano T., Tanabe M., Uechi M., Kanai K., Nakao R., Hoshi F., and Higuchi S. Evaluation of plasma C-terminal atrial natriuretic peptide in healthy cats and cats with heart disease. J Vet Intern Med 22 (2008) 135-139
16. Connolly D.J., Magalhaes R.J., Syme H.M., Boswood A., Fuentes V.L., Chu L., and Metcalf M. Circulating natriuretic peptides in cats with heart disease. J Vet Intern Med 22 (2008) 96-105
17. Biondo A.W., Ehrhart E.J., Sisson D.D., Bulmer B.J., De Morais H.S., and Solter P.F. Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy. Vet Pathol 40 (2003) 501-506
18. MacLean H.N., Abbott J.A., Ward D.L., Huckle W.R., Sisson D.D., and Pyle R.L. N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy. J Vet Intern Med 20 (2006) 284-289
19. Prosek R., Sisson D.D., Oyama M.A., Biondo A.W., and Solter P.E. Measurements of plasma endothelin immunoreactivity in healthy cats and cats with cardiomyopathy. J Vet Intern Med 18 (2004) 501-504
20. Herndon W.E., Kittleson M.D., Sanderson K., Drobatz K.J., Clifford C.A., Gelzer A., Summerfield N.J., Linde A., and Sleeper M.M. Cardiac troponin I in feline hypertrophic cardiomyopathy. J Vet Intern Med 16 (2002) 558-564
21. Baumwart R.D., and Meurs K.M. Assessment of plasma brain natriuretic peptide concentration in Boxers with arrhythmogenic right ventricular cardiomyopathy. Am J Vet Res 66 (2005) 2086-2089
22. Tarnow I., Olsen L.H., Kvart C., Hoglund K., Moesgaard S.G., Kamstrup T.S., Pedersen H.D., and Haggstrom J. Predictive value of natriuretic peptides in dogs with mitral valve disease. Vet J (2008) (on-line Aug 1, 2008)
23. Chetboul V., Tessier-Vetzel D., Escriou C., Tissier R., Carlos C., Boussouf M., Pouchelon J.L., Blot S., and Derumeaux G. Diagnostic potential of natriuretic peptides in the occult phase of golden retriever muscular dystrophy cardiomyopathy. J Vet Intern Med 18 (2004) 845-850
24. Oyama M.A., Sisson D.D., and Solter P.F. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Am J Vet Res 68 (2007) 42-47
25. Hori Y., Tsubaki M., Katou A., Ono Y., Yonezawa T., Li X., and Higuchi S.I. Evaluation of NT-Pro BNP and CT-ANP as markers of concentric hypertrophy in dogs with a model of compensated aortic stenosis. J Vet Intern Med 22 (2008) 1118-1123
26. Gardi J., Bíró E., Vecsernyés M., Julesz J., Nyári T., Tóth G., and Telegdy G. The effects of brain and C-type natriuretic peptides on corticotropin-releasing factor in brain of rats. Life Sci 60 (1997) 2111-2117